NIH-funded research NIH-funded research

Developing models to understand infectious diseases.

Official title: Pre-Clinical Models of Infectious Diseases

Funded at University of Saskatchewan · NIH-11197689 · Data updated 2026-11-12

This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Saskatchewan
NIH-funded
Lab location1 site (Saskatoon, Canada)
Project startJuly 15, 2024
Project endJuly 14, 2031
Funding year2024
Award (this year)$2,500
NIH project number75N93024D00040-0-759302400002-1
Project IDNIH-11197689 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of infectious diseases or those who may benefit from new therapeutic approaches.

Less likely to help

Patients with non-infectious diseases or those who do not have a risk of contracting infectious diseases may not receive any benefit from this research.

What this research studies

This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and effects. By using these models, researchers aim to test potential medical countermeasures and treatments before they are used in humans. Patients may benefit from the insights gained through this research, which could lead to improved therapies and preventive measures against infectious diseases.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments and preventive strategies for infectious diseases.

How similar studies have gone: Previous research has shown success in using pre-clinical models to develop treatments for infectious diseases, indicating that this approach is both tested and promising.

Where this research is happening

  • University of Saskatchewan
    Saskatoon, Canada
    Active

Related research

Other NIH-funded projects on the same topics.

  • Developing models to understand infectious diseases.

    This study is working on building models that mimic infectious diseases to help scientists learn how they work and find better treatments, which could lead to improved options for patients dealing with these illnesses.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-11197707

  • Developing models to understand infectious diseases.

    This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-11197697

  • Developing new biopharmaceutical products for infectious diseases

    This study is working on improving the way new medicines, like antibodies and proteins, are developed to help treat infectious diseases, so that patients can have better and more effective treatment options.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-10934791

  • Developing new treatments to combat bacterial resistance using biopharmaceuticals

    This study is working on new treatments to help fight stubborn bacterial infections that don't respond to regular antibiotics, so patients can have better options for getting better.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-10934790

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.